Viawealth, LLC Johnson & Johnson Transaction History

Viawealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $582 - $635	4 Added 0.3%	1,316 $206 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $244,527 - $273,933	-1,570 Reduced 54.48%	1,312 $204 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $1,543 - $1,661	10 Added 0.35%	2,882 $477 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $18,579 - $22,171	123 Added 4.47%	2,872 $445 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $440,389 - $494,242	2,749 New	2,749 $483 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Viawealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Viawealth, LLC with notifications on news.